HOLX Share Price

Open 43.51 Change Price %
High 43.62 1 Day -0.15 -0.34
Low 42.86 1 Week 0.35 0.81
Close 43.35 1 Month -1.23 -2.76
Volume 2720432 1 Year 8.94 25.98
52 Week High 46.05
52 Week Low 32.64
HOLX Important Levels
Resistance 2 44.05
Resistance 1 43.76
Pivot 43.28
Support 1 42.94
Support 2 42.65
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
DCTH 0.02 0.00%
SUSQ 14.20 -0.77%
ASTI 0.00 0.00%
SIRI 5.29 3.32%
More..
NASDAQ USA Top Gainers Stocks
SPIR 0.02 100.00%
LOCM 0.09 50.00%
NIHD 0.74 39.62%
NIHD 0.74 39.62%
WRES 0.09 28.57%
CGEI 0.28 27.27%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
AEZS 1.18 22.92%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
ULTR 0.05 -37.50%
More..

Hologic, Inc. (NASDAQ: HOLX)

HOLX Technical Analysis 3
As on 26th May 2017 HOLX Share Price closed @ 43.35 and we RECOMMEND Buy for LONG-TERM with Stoploss of 39.64 & Buy for SHORT-TERM with Stoploss of 43.25 we also expect STOCK to react on Following IMPORTANT LEVELS.
HOLX Target for May
1st Target up-side 46.83
2nd Target up-side 48.01
3rd Target up-side 49.18
1st Target down-side 43.47
2nd Target down-side 42.29
3rd Target down-side 41.12
HOLX Other Details
Segment EQ
Market Capital 5513593344.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.hologic.com
HOLX Address
HOLX
35 Crosby Drive
Bedford, MA 01730
United States
Phone: 781-999-7300
HOLX Latest News
Interactive Technical Analysis Chart Hologic, Inc. ( HOLX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Hologic, Inc.
HOLX Business Profile
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products to serving the healthcare needs of women. The Company operates in four segments: Breast Health, Diagnostics, GYN Surgical and Skeletal Health. The Company sells and services its products through a combination of direct sales and service forces and a network of independent distributors and sales representatives. On August 1, 2012, the Company acquired Gen-Probe Incorporated (Gen-Probe). Gen-Probe is engaged in molecular diagnostics products and services, which are used to diagnose human diseases, screen donated human blood and test transplant compatibility. In March 2013, it announced that it has completed its sale of the LIFECODES business unit to Immucor, Inc.